The FDA advisory panel unanimously supported mRNA-1010/mFLUSIVA for adults 50–64 and 65+, and the stock is already reacting ...

The AI data industry will continue to reinvent itself, and the companies that take the lead will do so by building a sustainable infrastructure.

Meta's AI Strategy Is Bigger Than Alexandr Wang and Bigger Than Any Single Model. Meta's $14.3 Billion Scale AI Investment ...

Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...

Data analysis is no longer a specialist skill reserved for analysts. It now supports finance, trading, ecommerce, marketing, ...

Definium Therapeutics surged ~50% after positive Phase 3 EMERGE data for DT120 in major depressive disorder, demonstrating rapid, robust, and durable efficacy.

Amazon.com's AI push, global expansion and diversified businesses support growth, but rising AI spending, debt and ...

Texas looks deep‑red on election maps. Republicans have held every statewide office for decades and still dominate the ...

Investors hope the labor pool is strong enough to keep the economy going but not too hot as to cause the Federal Reserve to ...

AMAT, MA, ABBV, VATE and BOF headline new research reports highlighting AI, payments, healthcare and microcap growth ...

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

Deadlines may have changed, but digital leaders need to do more and up the pace if they are to comply with the European Union (EU) AI Act, research with the diginomica network - our community of CIOs ...